This company has been marked as potentially delisted and may not be actively trading. LAVA Therapeutics (LAVA) News Today Add Share Share Headlines Stock AnalysisBuy This Stock LAVA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period 4 Biotech Stocks That Are Showing Weakness: Momentum Scores Fading Over The Past WeekSeptember 3, 2025 | benzinga.comLava Therapeutics reports Q2 EPS (32c) vs. (31c) last yearAugust 14, 2025 | msn.comXOMA Royalty to acquire HilleVax and LAVA Therapeutics in separate dealsAugust 4, 2025 | investing.comLAVA Therapeutics NV News (LVTX) - Investing.comJuly 2, 2025 | investing.comLava Therapeutics expects $1M of expenses related to restructuring planMarch 28, 2025 | markets.businessinsider.comJMP Securities Sticks to Its Hold Rating for LAVA Therapeutics (LVTX)March 28, 2025 | markets.businessinsider.comLAVA Therapeutics NV Reports Q4 2024 EPS of -0.30, Revenue of $2. ...March 28, 2025 | gurufocus.comHC Wainwright & Co. Downgrades LAVA Therapeutics N.V. (LVTX)February 28, 2025 | msn.comLava Therapeutics downgraded to Neutral from Buy at H.C. WainwrightFebruary 27, 2025 | markets.businessinsider.comLAVA Therapeutics N.V.: LAVA Announces Evaluation of Strategic OptionsFebruary 25, 2025 | finanznachrichten.deLAVA Announces Evaluation of Strategic OptionsFebruary 25, 2025 | finance.yahoo.comLava Therapeutics implements restructuring plan, workforce reduction of 30%February 25, 2025 | markets.businessinsider.comLVTX stock touches 52-week low at $0.88 amid market challengesFebruary 12, 2025 | msn.comGamma Delta T Cell Cancer Therapy Clinical Trials OverviewJanuary 29, 2025 | finance.yahoo.comJMP Securities Downgrades LAVA Therapeutics N.V. (LVTX)December 12, 2024 | msn.comLAVA Therapeutics N.V.: LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027December 10, 2024 | finanznachrichten.deKling Biotherapeutics Strengthens Leadership Team to Advance Pipeline Using its Proprietary Primary B-Cell Selection and Evolution PlatformDecember 10, 2024 | ca.finance.yahoo.comLava Therapeutics reports Q3 EPS (46c) vs (34c) last yearDecember 10, 2024 | markets.businessinsider.com10 New Pieces of Echoes of Wisdom Lore Zelda Fans Need to KnowOctober 14, 2024 | msn.comGoron Race Guide for Zelda: Echoes of WisdomOctober 12, 2024 | msn.comThe Legend of Zelda: Echoes of Wisdom - 10 Best Echoes For TraversalSeptember 29, 2024 | msn.comHow To Restore The Eldin Volcano Temple Rift In The Legend Of Zelda: Echoes Of WisdomSeptember 27, 2024 | msn.comThe Legend of Zelda: Echoes of Wisdom review – top-down magic reinvented for the betterSeptember 25, 2024 | mirror.co.ukMThe Legend of Zelda: Echoes of Wisdom review – "A refreshing, magic-filled retool of the Link's Awakening engine"September 25, 2024 | msn.comLAVA Therapeutics N.V.: LAVA Reports Second Quarter 2024 Financial Results and Business UpdateAugust 20, 2024 | finanznachrichten.deTake a tour of Hyrule in the new Legend of Zelda: Echoes of Wisdom trailerAugust 6, 2024 | msn.comNew trailer for The Legend of Zelda: Echoes of Wisdom arrivesAugust 6, 2024 | msn.comZelda’s big adventure gets a new trailerAugust 6, 2024 | msn.comThe 14 best Zelda-likes to play after Tears of the KingdomJuly 23, 2024 | msn.comZelda: Tears Of The Kingdom Goron City LocationMay 29, 2024 | msn.comLAVA Therapeutics N.V.: LAVA Provides Business Updates and Reports First Quarter 2024 Financial ResultsMay 21, 2024 | finanznachrichten.deLVTX Stock Earnings: LAVA Therapeutics Beats EPS, Misses Revenue for Q1 2024May 21, 2024 | msn.comStrong Buy Rating for LAVA Therapeutics on Promising Clinical and Financial OutlookMarch 21, 2024 | markets.businessinsider.comLAVA Therapeutics Full Year 2023 Earnings: Revenues DisappointMarch 21, 2024 | uk.finance.yahoo.comLVTX Stock Earnings: LAVA Therapeutics Misses EPS, Misses Revenue for Q4 2023March 20, 2024 | investorplace.comLiverpool XI vs Manchester United: Starting lineup, confirmed team news, injury latest for FA Cup todayMarch 17, 2024 | msn.comLVTX Apr 2024 2.500 callMarch 16, 2024 | finance.yahoo.comLAVA Announces Clinical Development Milestone Achieved by Pfizer for PF-08046052 (formerly SGN-EGFRd2/LAVA-1223)March 5, 2024 | finance.yahoo.comPRGS, EVER and LVTX are among after hour moversFebruary 26, 2024 | seekingalpha.comStrong Buy Rating for LAVA Therapeutics Amid Strategic Partnerships and Promising Clinical AdvancementsFebruary 2, 2024 | markets.businessinsider.comWhy Humana Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionJanuary 25, 2024 | msn.comDow Surges Over 100 Points; US GDP Growth Tops EstimatesJanuary 25, 2024 | benzinga.comWhy Is Cancer Focused LAVA Therapeutics Nano Cap Stock Trading Higher Today?January 25, 2024 | msn.comNew Alzheimer’s Treatment Accelerates Removal of Plaque From The Brain In Clinical TrialsJanuary 15, 2024 | msn.comPsychedelics gave terminal patients relief from their intense anxietyJanuary 13, 2024 | msn.comAnalysts Are Bullish on These Healthcare Stocks: Genelux Corp. (GNLX), Calliditas Therapeutics (CALT)November 27, 2023 | markets.businessinsider.comLAVA Therapeutics N.V.: Lava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 16, 2023 | finanznachrichten.deMemo Therapeutics AG Appoints Erik van den Berg as Chief Executive OfficerNovember 16, 2023 | businesswire.comLAVA Therapeutics GAAP EPS of -$0.34 beats by $0.14November 16, 2023 | msn.comLava Therapeutics Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 16, 2023 | finance.yahoo.com Get LAVA Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LAVA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LAVA Media Mentions By Week LAVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LAVA News Sentiment▼0.000.67▲Average News Sentiment LAVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LAVA Articles This Week▼00▲LAVA Articles Average Week Get the Latest News and Ratings for LAVA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for LAVA Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LAVA) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LAVA Therapeutics NV Please log in to your account or sign up in order to add this asset to your watchlist. Share LAVA Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LAVA Stock Alerts